• Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$27.33
+0 (0.00%)

This chart shows the closing price for GNGBY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Getinge Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GNGBY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GNGBY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for Getinge in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $27.33.

This chart shows the closing price for GNGBY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 4 investment analysts is to hold stock in Getinge. This rating has held steady since September 2026, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/9/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/7/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/5/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/3/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/4/2026
  • 1 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/2/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/1/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/31/2026

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
9/24/2026Pareto SecuritiesDowngradeStrong-Buy ➝ Hold
9/17/2026Zacks ResearchDowngradeStrong-Buy ➝ Hold
9/2/2026UBS GroupInitiated CoverageHold
8/31/2026Nordea Equity ResearchDowngradeBuy ➝ Hold
7/21/2026Zacks ResearchUpgradeHold ➝ Strong-Buy
4/23/2026Zacks ResearchUpgradeHold
10/22/2025Nordea Equity ResearchUpgradeHold ➝ Buy
6/17/2025Sanford C. BernsteinUpgradeHold
7/7/2023Morgan StanleyDowngradeOverweight ➝ Equal Weight
6/28/2023HandelsbankenUpgradeMarket Perform ➝ Outperform
6/20/2023DNB MarketsDowngradeBuy ➝ Hold
4/27/2023DNB MarketsUpgradeHold ➝ Buy
4/11/2023HandelsbankenDowngradeOutperform ➝ Market Perform
2/2/2023Pareto SecuritiesDowngradeBuy ➝ Hold
1/18/2023Morgan StanleyLower TargetOverweight ➝ OverweightSEK 274 ➝ SEK 250
1/3/2023JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
12/30/2022DNB MarketsDowngradeBuy ➝ Hold
10/20/2022JPMorgan Chase & Co.Lower TargetNeutral ➝ NeutralSEK 331 ➝ SEK 285
10/20/2022Nordea Equity ResearchUpgradeHold ➝ Buy
10/18/2022Morgan StanleyInitiated CoverageOverweight
7/20/2022JPMorgan Chase & Co.Lower TargetNeutral ➝ NeutralSEK 344 ➝ SEK 331
6/15/2022JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
6/15/2022Nordea Equity ResearchDowngradeBuy ➝ Hold
6/13/2022CheuvreuxDowngradeBuy ➝ HoldSEK 435 ➝ SEK 280
6/13/2022Kepler Capital MarketsDowngradeBuy ➝ HoldSEK 435 ➝ SEK 280
4/27/2022JPMorgan Chase & Co.Lower TargetOverweight ➝ OverweightSEK 430 ➝ SEK 425
3/22/2022JPMorgan Chase & Co.Boost TargetSEK 425 ➝ SEK 430
3/9/2022Jefferies Financial GroupInitiated CoverageHold
1/31/2022JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
1/19/2022Pareto SecuritiesUpgradeHold ➝ Buy
11/15/2021JPMorgan Chase & Co.Reiterated RatingNeutral
(Data available from 11/1/2021 forward)

News Sentiment Rating

0.19 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/4/2026
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/4/2026
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/3/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/3/2026
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/2/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/1/2026
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/1/2026
  • 1 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
10/31/2026

Current Sentiment

  • 1 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Getinge logo
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
Read More

Today's Range

Now: $27.33
Low: $27.33
High: $27.33

50 Day Range

MA: $25.38
Low: $23.93
High: $27.33

52 Week Range

Now: $27.33
Low: $18.99
High: $27.33

Volume

60 shs

Average Volume

986 shs

Market Capitalization

$7.44 billion

P/E Ratio

24.85

Dividend Yield

1.05%

Beta

0.95

Frequently Asked Questions

What sell-side analysts currently cover shares of Getinge?

The following Wall Street research analysts have issued reports on Getinge in the last twelve months: Nordea Equity Research, Pareto Securities, UBS Group AG, and Zacks Research.
View the latest analyst ratings for GNGBY.

What is the current price target for Getinge?

0 Wall Street analysts have set twelve-month price targets for Getinge in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Getinge in the next year.
View the latest price targets for GNGBY.

What is the current consensus analyst rating for Getinge?

Getinge currently has 4 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in GNGBY, but not buy more shares or sell existing shares.
View the latest ratings for GNGBY.

What other companies compete with Getinge?

How do I contact Getinge's investor relations team?

Getinge's physical mailing address is Lindholmspiren 7A, Gothenburg, VG, 417 56. The company's listed phone number is (610) 335-0000 and its investor relations email address is [email protected]. The official website for Getinge is www.getinge.com. Learn More about contacing Getinge investor relations.